At Fosun Health, gastric cancer diagnosis must answer three critical questions: Is it cancer? How deep has it invaded the stomach wall? What is its molecular "fingerprint"? Our integrated pathway delivers all answers within days:
We perform magnifying endoscopy with NBI (Narrow Band Imaging) or chromoendoscopy to visualize microvascular patterns invisible to standard scopes. Targeted biopsy confirms histology, Lauren classification, and differentiation grade.
The most accurate tool for T-staging. EUS reveals how deeply the tumor has penetrated the stomach wall and whether nearby lymph nodes are involved—directly determining whether endoscopic resection, function-preserving surgery, or radical gastrectomy is appropriate.
Evaluates local tumor extent, perigastric lymph nodes, and distant metastases (liver, peritoneum, lung).
Detects occult metastases and peritoneal implants that CT may miss.
Using NGS (Next-Generation Sequencing)，we analyze HER2, CLDN18.2, MSI/dMMR, EBV, PD-L1, and over 300 cancer-related genes. This determines your eligibility for trastuzumab, zolbetuximab (anti-CLDN18.2), immunotherapy, or novel combination regimens—ensuring your treatment is matched to your tumor's unique biology.
